These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 25988740)

  • 21. Effectiveness and safety of drugs used for stroke prevention in a cohort of non-valvular atrial fibrillation patients from a primary care electronic database.
    Giner-Soriano M; Roso-Llorach A; Vedia Urgell C; Castells X; Capellà D; Ferreira-González I; Elorza-Ricart JM; Casajuana M; Troncoso Mariño A; Diògene E; Bolíbar B; Violan C; Morros R
    Pharmacoepidemiol Drug Saf; 2017 Jan; 26(1):97-107. PubMed ID: 27868275
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stroke risk in hypertrophic cardiomyopathy patients with atrial fibrillation: a nationwide database study.
    Hsu JC; Huang YT; Lin LY
    Aging (Albany NY); 2020 Nov; 12(23):24219-24227. PubMed ID: 33226371
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Usefulness of CHADS2 and CHA2DS2-VASc Scores in the Prediction of New-Onset Atrial Fibrillation: A Population-Based Study.
    Saliba W; Gronich N; Barnett-Griness O; Rennert G
    Am J Med; 2016 Aug; 129(8):843-9. PubMed ID: 27012854
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Warfarin prescription in patients with nonvalvular atrial fibrillation and one non-gender-related risk factor (CHA
    Denas G; Zoppellaro G; Padayattil Jose S; Antonucci E; Marongiu F; Poli D; Testa S; Tripodi A; Palareti G; Pengo V
    Cardiovasc Ther; 2018 Feb; 36(1):. PubMed ID: 29078033
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is an Oral Anticoagulant Necessary for Young Atrial Fibrillation Patients With a CHA2DS2-VASc Score of 1 (Men) or 2 (Women)?
    Hung Y; Chao TF; Liu CJ; Tuan TC; Lin YJ; Chang SL; Lo LW; Hu YF; Liao JN; Chung FP; Lin WY; Lin WS; Cheng SM; Chen TJ; Lip GY; Chen SA
    J Am Heart Assoc; 2016 Oct; 5(10):. PubMed ID: 27702803
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differences in stroke risk and cardiovascular mortality for Aboriginal and other Australian patients with atrial fibrillation.
    Nedkoff L; Kelty EA; Hung J; Thompson SC; Katzenellenbogen JM
    Med J Aust; 2020 Mar; 212(5):215-221. PubMed ID: 32030754
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neutrophil/lymphocyte ratio is related to the severity of coronary artery disease and clinical outcome in patients undergoing angiography.
    Arbel Y; Finkelstein A; Halkin A; Birati EY; Revivo M; Zuzut M; Shevach A; Berliner S; Herz I; Keren G; Banai S
    Atherosclerosis; 2012 Dec; 225(2):456-60. PubMed ID: 23040448
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of Baseline Neutrophil-to-Lymphocyte Ratio on Long-Term Prognosis in Patients With Atrial Fibrillation.
    Wu S; Yang YM; Zhu J; Ren JM; Wang J; Zhang H; Shao XH
    Angiology; 2021 Oct; 72(9):819-828. PubMed ID: 33719617
    [TBL] [Abstract][Full Text] [Related]  

  • 29. sST2 levels are associated with all-cause mortality in anticoagulated patients with atrial fibrillation.
    Vílchez JA; Pérez-Cuellar M; Marín F; Gallego P; Manzano-Fernández S; Valdés M; Vicente V; Noguera-Velasco JA; Lip GY; Ordóñez-Llanos J; Roldán V
    Eur J Clin Invest; 2015 Sep; 45(9):899-905. PubMed ID: 26081996
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlation between cardiac rhythm, left atrial appendage flow velocity, and CHA
    Zuo K; Sun L; Yang X; Lyu X; Li K
    Clin Cardiol; 2017 Feb; 40(2):120-125. PubMed ID: 28075503
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oral Anticoagulation and the Risk of Stroke or Death in Patients With Atrial Fibrillation and One Additional Stroke Risk Factor: The Loire Valley Atrial Fibrillation Project.
    Fauchier L; Lecoq C; Clementy N; Bernard A; Angoulvant D; Ivanes F; Babuty D; Lip GY
    Chest; 2016 Apr; 149(4):960-8. PubMed ID: 26425935
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-sensitivity troponin T and risk stratification in patients with atrial fibrillation during treatment with apixaban or warfarin.
    Hijazi Z; Wallentin L; Siegbahn A; Andersson U; Alexander JH; Atar D; Gersh BJ; Hanna M; Harjola VP; Horowitz JD; Husted S; Hylek EM; Lopes RD; McMurray JJ; Granger CB;
    J Am Coll Cardiol; 2014 Jan 7-14; 63(1):52-61. PubMed ID: 24055845
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stroke risk reassessment and oral anticoagulant initiation in primary care patients with atrial fibrillation: A ten-year follow-up.
    Bezabhe WM; Bereznicki LR; Radford J; Wimmer BC; Salahudeen MS; Garrahy E; Bindoff I; Peterson GM
    Eur J Clin Invest; 2021 Jun; 51(6):e13489. PubMed ID: 33426646
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Atrial fibrillation diagnosed after stroke and dementia risk: cohort study of first-ever ischaemic stroke patients aged 65 or older.
    Krawczyk M; Fridman S; Cheng Y; Fang J; Saposnik G; Sposato LA
    Europace; 2019 Dec; 21(12):1793-1801. PubMed ID: 31531673
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic impact of renal dysfunction in patients with acute coronary syndrome-role beyond the CHA2 DS2 -VASc score: Data from Taiwan acute coronary syndrome full spectrum registry.
    Chua SK; Lo HM; Chiu CZ; Shyu KG;
    Nephrology (Carlton); 2016 Jul; 21(7):583-91. PubMed ID: 26469710
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Geriatric conditions do not predict stroke or bleeding in long-term care residents with atrial fibrillation.
    Kapoor A; Patel J; Chen Z; Crawford S; McManus D; Gurwitz J; Shireman TI; Zhang N
    J Am Geriatr Soc; 2022 Apr; 70(4):1218-1227. PubMed ID: 34902164
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Catheter ablation of atrial fibrillation is associated with reduced risk of stroke and mortality: A propensity score-matched analysis.
    Saliba W; Schliamser JE; Lavi I; Barnett-Griness O; Gronich N; Rennert G
    Heart Rhythm; 2017 May; 14(5):635-642. PubMed ID: 28189823
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Left Atrial Size and Long-Term Risk of Recurrent Stroke After Acute Ischemic Stroke in Patients With Nonvalvular Atrial Fibrillation.
    Ogata T; Matsuo R; Kiyuna F; Hata J; Ago T; Tsuboi Y; Kitazono T; Kamouchi M;
    J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28862939
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stroke and Thromboembolism in Warfarin-Treated Patients with Atrial Fibrillation: Comparing the CHA2DS2-VASc and GARFIELD-AF Risk Scores.
    Proietti M; Rivera-Caravaca JM; Esteve-Pastor MA; Marín F; Lip GYH
    Thromb Haemost; 2021 Aug; 121(8):1107-1114. PubMed ID: 33296920
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CHA
    Su CH; Tsao TF; Chen AC; Chang KW; Yang YS; Ueng KC; Tsai CF
    Eur J Clin Invest; 2018 Mar; 48(3):. PubMed ID: 29288496
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.